Literature DB >> 9048725

Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.

A M Bakheit, C D Ward, D L McLellan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048725      PMCID: PMC486736          DOI: 10.1136/jnnp.62.2.198

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Neuromuscular effects distant from the site of botulinum neurotoxin injection.

Authors:  R K Olney; M J Aminoff; D J Gelb; D H Lowenstein
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

2.  Effect of ethosuximide on rest tremor in the MPTP monkey model.

Authors:  B Gomez-Mancilla; J F Latulippe; R Boucher; P J Bédard
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

3.  Botulinum toxin treatment of spasmodic torticollis.

Authors:  T J Anderson; J Rivest; R Stell; M J Steiger; H Cohen; P D Thompson; C D Marsden
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 5.344

4.  Distant effects of local injection of botulinum toxin.

Authors:  D J Lange; M F Brin; C L Warner; S Fahn; R E Lovelace
Journal:  Muscle Nerve       Date:  1987 Jul-Aug       Impact factor: 3.217

  4 in total
  22 in total

Review 1.  Uses of botulinum toxin injection in medicine today.

Authors:  A Münchau; K P Bhatia
Journal:  BMJ       Date:  2000-01-15

2.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 3.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.

Authors:  Beth E Crowner; Diego Torres-Russotto; Alexandre R Carter; Brad A Racette
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

Review 5.  Botulinum toxin A treatment of adult upper and lower limb spasticity.

Authors:  S Hesse; B Brandi-Hesse; A Bardeleben; C Werner; M Funk
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy.

Authors:  Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-10-16       Impact factor: 3.575

Review 7.  Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.

Authors:  Andrea Santamato; Francesco Panza
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

8.  Botulinum toxin.

Authors:  P K Nigam; Anjana Nigam
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 9.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  The pharmacological management of post-stroke muscle spasticity.

Authors:  Abdel Magid O Bakheit
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.